Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressDividends payablesGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (NHPAP) Minority Interest (2016 - 2025)

Historic Minority Interest for National Healthcare Properties (NHPAP) over the last 12 years, with Q3 2025 value amounting to $5.4 million.

  • National Healthcare Properties' Minority Interest fell 404.74% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 404.74%. This contributed to the annual value of $5.6 million for FY2024, which is 1343.91% down from last year.
  • Latest data reveals that National Healthcare Properties reported Minority Interest of $5.4 million as of Q3 2025, which was down 404.74% from $5.4 million recorded in Q2 2025.
  • National Healthcare Properties' Minority Interest's 5-year high stood at $6.9 million during Q1 2022, with a 5-year trough of $4.4 million in Q2 2021.
  • For the 5-year period, National Healthcare Properties' Minority Interest averaged around $6.1 million, with its median value being $6.4 million (2023).
  • In the last 5 years, National Healthcare Properties' Minority Interest crashed by 1544.78% in 2021 and then surged by 5614.27% in 2022.
  • Quarter analysis of 5 years shows National Healthcare Properties' Minority Interest stood at $6.7 million in 2021, then fell by 2.28% to $6.6 million in 2022, then decreased by 1.86% to $6.4 million in 2023, then dropped by 13.44% to $5.6 million in 2024, then fell by 2.44% to $5.4 million in 2025.
  • Its Minority Interest stands at $5.4 million for Q3 2025, versus $5.4 million for Q2 2025 and $5.5 million for Q1 2025.